or
forgot password

Enrichment and Purging of Stem Cells in the Treatment of Non-Hodgkin's Lymphoma


N/A
N/A
75 Years
Not Enrolling
Both
Lymphoma, Non-Hodgkin

Thank you

Trial Information

Enrichment and Purging of Stem Cells in the Treatment of Non-Hodgkin's Lymphoma


To study the use of peripheral blood stem cells which have been treated in an effort to
remove tumor cells. The researchers hope to learn whether or not this will be more effective
in removing the tumor cells as compared to other methods of purging (the removal of cancer
cells).


Inclusion Criteria:

- relapsed NHL

Exclusion Criteria:- liver dysfunction

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

PCR positivity in peripheral blood cell collections after cyclophosphamide

Outcome Time Frame:

unknown

Safety Issue:

No

Principal Investigator

Robert S Negrin

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

BMT4IJ

NCT ID:

NCT00186355

Start Date:

October 2003

Completion Date:

February 2010

Related Keywords:

  • Lymphoma, Non-Hodgkin
  • Lymphoma
  • Lymphoma, Non-Hodgkin

Name

Location
Stanford University School of Medicine Stanford, California  94305-5317